First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses
by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with
Updated on: January 26,2024
First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses
by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with
Updated on:January 26,2024
